Boehringer Ingelheim RCV GmbH & Co KG
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Austria
- Registered address
- Dr. Boehringer Gasse 5-11, Vienna, Austria A1121, Austria (AUT)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3003433722 · DUNS 300010883
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-07-04
- NAIVaccines and Allergenic Products2024-11-12
- NAIDrug Quality Assurance2023-03-02
- NAIVaccines and Allergenic Products2022-09-16
- VAIDrug Quality Assurance2021-01-28
- VAIDrug Quality Assurance2014-11-11
- NAIDrug Quality Assurance2013-11-15
- VAIDrug Quality Assurance2013-04-26
- VAIDrug Quality Assurance2012-03-23
- VAIDrug Quality Assurance2010-01-28
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- anakinraSwedish Orphan Biovitrum AB (publ)
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.